227 related articles for article (PubMed ID: 12060875)
1. The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials.
Husain S; Singh N
Clin Infect Dis; 2002 Jul; 35(1):53-61. PubMed ID: 12060875
[TBL] [Abstract][Full Text] [Related]
2. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.
Peleg AY; Husain S; Kwak EJ; Silveira FP; Ndirangu M; Tran J; Shutt KA; Shapiro R; Thai N; Abu-Elmagd K; McCurry KR; Marcos A; Paterson DL
Clin Infect Dis; 2007 Jan; 44(2):204-12. PubMed ID: 17173218
[TBL] [Abstract][Full Text] [Related]
3. Opportunistic infections in renal allograft recipients.
Gupta RK
Transplant Proc; 2007 Apr; 39(3):731-3. PubMed ID: 17445584
[TBL] [Abstract][Full Text] [Related]
4. [Infections in solid organ transplant recipients].
Cuellar-Rodríguez J; Sierra-Madero JG
Rev Invest Clin; 2005; 57(2):368-80. PubMed ID: 16524080
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial and immunosuppressive drug interactions in solid organ transplant recipients.
Berdaguer S; Bautista J; Brunet M; Cisneros JM
Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():86-92. PubMed ID: 22542040
[TBL] [Abstract][Full Text] [Related]
6. Infectious risk in pediatric organ transplant recipients: is it increased with the new immunosuppressive agents?
Renoult E; Buteau C; Lamarre V; Turgeon N; Tapiero B
Pediatr Transplant; 2005 Aug; 9(4):470-9. PubMed ID: 16048599
[TBL] [Abstract][Full Text] [Related]
7. Infectious complications of immunosuppressive medications in organ transplant recipients.
Green M; Michaels MG
Pediatr Infect Dis J; 2007 May; 26(5):443-4. PubMed ID: 17468657
[No Abstract] [Full Text] [Related]
8. [Infections in renal transplant recipients in Norway].
Midtvedt K
Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3621-3. PubMed ID: 10563182
[TBL] [Abstract][Full Text] [Related]
9. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design.
Singh N
Clin Infect Dis; 2004 Oct; 39 Suppl 4():S200-6. PubMed ID: 15546118
[TBL] [Abstract][Full Text] [Related]
10. Prevention of infection caused by Pneumocystis carinii in transplant recipients.
Fishman JA
Clin Infect Dis; 2001 Oct; 33(8):1397-405. PubMed ID: 11565082
[TBL] [Abstract][Full Text] [Related]
11. How I treat cryptococcosis in organ transplant recipients.
Singh N
Transplantation; 2012 Jan; 93(1):17-21. PubMed ID: 22015465
[TBL] [Abstract][Full Text] [Related]
12. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
Limaye AP
Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
[TBL] [Abstract][Full Text] [Related]
13. Infections in immunocompromised hosts and organ transplant recipients: essentials.
Fishman JA
Liver Transpl; 2011 Nov; 17 Suppl 3():S34-7. PubMed ID: 21748845
[TBL] [Abstract][Full Text] [Related]
14. Microbiologic consequences of new approaches to managing hematologic malignancies.
Blijlevens NM; Donnelly JP; de Pauw BE
Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116
[TBL] [Abstract][Full Text] [Related]
15. Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients.
Singh N; Heitman J
Transplantation; 2004 Mar; 77(6):795-800. PubMed ID: 15077015
[TBL] [Abstract][Full Text] [Related]
16. Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regimens.
Singh N
Curr Opin Infect Dis; 2005 Aug; 18(4):342-5. PubMed ID: 15985832
[TBL] [Abstract][Full Text] [Related]
17. Skin infections in organ transplant recipients.
Ulrich C; Hackethal M; Meyer T; Geusau A; Nindl I; Ulrich M; Forschner T; Sterry W; Stockfleth E
J Dtsch Dermatol Ges; 2008 Feb; 6(2):98-105. PubMed ID: 17995969
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
Singh N
J Clin Virol; 2006 Apr; 35(4):474-7. PubMed ID: 16406798
[TBL] [Abstract][Full Text] [Related]
19. Infection in organ transplantation: risk factors and evolving patterns of infection.
Fishman JA; Issa NC
Infect Dis Clin North Am; 2010 Jun; 24(2):273-83. PubMed ID: 20466270
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.
Aguado JM; Torre-Cisneros J; Fortún J; Benito N; Meije Y; Doblas A; Muñoz P
Clin Infect Dis; 2009 May; 48(9):1276-84. PubMed ID: 19320593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
